Search hospitals > North Dakota > Fargo
Lillestol Research, LLC
Claim this profileFargo, North Dakota 58104
Global Leader in Diabetes
Global Leader in Type 2 Diabetes
Conducts research for Obesity
Conducts research for Cardiovascular Disease
Conducts research for Osteoarthritis
106 reported clinical trials
4 medical researchers
Summary
Lillestol Research, LLC is a medical facility located in Fargo, North Dakota. This center is recognized for care of Diabetes, Type 2 Diabetes, Obesity, Cardiovascular Disease, Osteoarthritis and other specialties. Lillestol Research, LLC is involved with conducting 106 clinical trials across 89 conditions. There are 4 research doctors associated with this hospital, such as Michael J Lillestol, Prafulla Shembalkar, Prafulla Keshaorao Shembalkar, and Lillestol.Top PIs
Michael J LillestolLillestol Research4 years of reported clinical research
Studies Obesity
Studies Diabetes
22 reported clinical trials
27 drugs studied
Prafulla ShembalkarGetwell Hospital & Research Institute4 years of reported clinical research
Studies Migraine
4 reported clinical trials
3 drugs studied
Prafulla Keshaorao ShembalkarLillestol Research4 years of reported clinical research
Studies Migraine
4 reported clinical trials
3 drugs studied
LillestolLillestol Research LLC2 years of reported clinical research
Studies Cardiovascular Disease
Studies Atherosclerosis
1 reported clinical trial
2 drugs studied
Clinical Trials running at Lillestol Research, LLC
Obesity
Type 2 Diabetes
Obstructive Sleep Apnea
Cardiovascular Disease
Migraine
Diabetes
Chronic Kidney Disease
Non-alcoholic Fatty Liver Disease
Osteoarthritis
High Cholesterol
Orforglipron
for Type 2 Diabetes and Obesity
The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes and obesity or overweight at increased cardiovascular risk. The study will last approximately 2 years may include up to 27 visits.
Recruiting2 awards Phase 3
Retatrutide
for Type 2 Diabetes and Obesity
The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have obesity or overweight (J1I-MC-GZBK master protocol) including a subset of participants who have obstructive sleep apnea (OSA) (J1I-MC-GSA2). The study will last about 89 weeks and will include up to 24 visits.
Recruiting1 award Phase 37 criteria
Retatrutide
for Obesity
The purpose of this study is to evaluate the efficacy and safety of retatrutide in participants who have obesity or overweight (J1I-MC-GZBJ master protocol) including subsets of participants who have knee osteoarthritis (OA) (J1I-MC-GOA1) or who have obstructive sleep apnea (OSA) (J1I-MC-GSA1). This study will last about 89 weeks and will include up to 24 visits.
Recruiting1 award Phase 39 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Lillestol Research, LLC?
Lillestol Research, LLC is a medical facility located in Fargo, North Dakota. This center is recognized for care of Diabetes, Type 2 Diabetes, Obesity, Cardiovascular Disease, Osteoarthritis and other specialties. Lillestol Research, LLC is involved with conducting 106 clinical trials across 89 conditions. There are 4 research doctors associated with this hospital, such as Michael J Lillestol, Prafulla Shembalkar, Prafulla Keshaorao Shembalkar, and Lillestol.